Literature DB >> 28445802

NMNAT: It's an NAD+ synthase… It's a chaperone… It's a neuroprotector.

Jennifer M Brazill1, Chong Li1, Yi Zhu1, R Grace Zhai2.   

Abstract

Nicotinamide mononucleotide adenylyl transferases (NMNATs) are a family of highly conserved proteins indispensable for cellular homeostasis. NMNATs are classically known for their enzymatic function of catalyzing NAD+ synthesis, but also have gained a reputation as essential neuronal maintenance factors. NMNAT deficiency has been associated with various human diseases with pronounced consequences on neural tissues, underscoring the importance of the neuronal maintenance and protective roles of these proteins. New mechanistic studies have challenged the role of NMNAT-catalyzed NAD+ production in delaying Wallerian degeneration and have specified new mechanisms of NMNAT's chaperone function critical for neuronal health. Progress in understanding the regulation of NMNAT has uncovered a neuronal stress response with great therapeutic promise for treating various neurodegenerative conditions.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28445802      PMCID: PMC5515290          DOI: 10.1016/j.gde.2017.03.014

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  45 in total

Review 1.  Axon Self-Destruction: New Links among SARM1, MAPKs, and NAD+ Metabolism.

Authors:  Josiah Gerdts; Daniel W Summers; Jeffrey Milbrandt; Aaron DiAntonio
Journal:  Neuron       Date:  2016-02-03       Impact factor: 17.173

2.  Nmnat exerts neuroprotective effects in dendrites and axons.

Authors:  Yuhui Wen; Jay Z Parrish; Ruina He; R Grace Zhai; Michael D Kim
Journal:  Mol Cell Neurosci       Date:  2011-05-09       Impact factor: 4.314

3.  Nicotinamide mononucleotide adenylyl transferase 1 protects against acute neurodegeneration in developing CNS by inhibiting excitotoxic-necrotic cell death.

Authors:  Philip B Verghese; Yo Sasaki; Donghan Yang; Floy Stewart; Fatima Sabar; Mary Beth Finn; Christine M Wroge; Steven Mennerick; Jeffrey J Neil; Jeffrey Milbrandt; David M Holtzman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-04       Impact factor: 11.205

4.  Characterization of Leber Congenital Amaurosis-associated NMNAT1 Mutants.

Authors:  Yo Sasaki; Zachary Margolin; Benjamin Borgo; James J Havranek; Jeffrey Milbrandt
Journal:  J Biol Chem       Date:  2015-05-27       Impact factor: 5.157

5.  Nmnat2 delays axon degeneration in superior cervical ganglia dependent on its NAD synthesis activity.

Authors:  Tingting Yan; Yan Feng; Jin Zheng; Xinjian Ge; Yi Zhang; Dongmei Wu; Jian Zhao; Qiwei Zhai
Journal:  Neurochem Int       Date:  2009-09-22       Impact factor: 3.921

6.  Exome sequencing identifies NMNAT1 mutations as a cause of Leber congenital amaurosis.

Authors:  Pei-Wen Chiang; Juan Wang; Yang Chen; Quan Fu; Jing Zhong; Yanhua Chen; Xin Yi; Renhua Wu; Haixue Gan; Yong Shi; Yanling Chen; Christopher Barnett; Dianna Wheaton; Megan Day; Joanne Sutherland; Elise Heon; Richard G Weleber; Luis Alexandre Rassi Gabriel; Peikuan Cong; KuangHsiang Chuang; Sheng Ye; Juliana Maria Ferraz Sallum; Ming Qi
Journal:  Nat Genet       Date:  2012-07-29       Impact factor: 38.330

7.  Protection of mouse retinal ganglion cell axons and soma from glaucomatous and ischemic injury by cytoplasmic overexpression of Nmnat1.

Authors:  Yanli Zhu; Lihong Zhang; Yo Sasaki; Jeffrey Milbrandt; Jeffrey M Gidday
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-02       Impact factor: 4.799

8.  Nicotinamide mononucleotide adenylyltransferase expression in mitochondrial matrix delays Wallerian degeneration.

Authors:  Naoki Yahata; Shigeki Yuasa; Toshiyuki Araki
Journal:  J Neurosci       Date:  2009-05-13       Impact factor: 6.167

9.  A genome-wide gene-expression analysis and database in transgenic mice during development of amyloid or tau pathology.

Authors:  Mar Matarin; Dervis A Salih; Marina Yasvoina; Damian M Cummings; Sebastian Guelfi; Wenfei Liu; Muzammil A Nahaboo Solim; Thomas G Moens; Rocio Moreno Paublete; Shabinah S Ali; Marina Perona; Roshni Desai; Kenneth J Smith; Judy Latcham; Michael Fulleylove; Jill C Richardson; John Hardy; Frances A Edwards
Journal:  Cell Rep       Date:  2015-01-22       Impact factor: 9.423

10.  Two for the Price of One: A Neuroprotective Chaperone Kit within NAD Synthase Protein NMNAT2.

Authors:  Angela Lavado-Roldán; Rafael Fernández-Chacón
Journal:  PLoS Biol       Date:  2016-07-25       Impact factor: 8.029

View more
  31 in total

1.  Severe biallelic loss-of-function mutations in nicotinamide mononucleotide adenylyltransferase 2 (NMNAT2) in two fetuses with fetal akinesia deformation sequence.

Authors:  Marshall Lukacs; Jonathan Gilley; Yi Zhu; Giuseppe Orsomando; Carlo Angeletti; Jiaqi Liu; Xiuna Yang; Joun Park; Robert J Hopkin; Michael P Coleman; R Grace Zhai; Rolf W Stottmann
Journal:  Exp Neurol       Date:  2019-05-25       Impact factor: 5.330

Review 2.  Subcellular compartmentalization of NAD+ and its role in cancer: A sereNADe of metabolic melodies.

Authors:  Yi Zhu; Jiaqi Liu; Joun Park; Priyamvada Rai; Rong G Zhai
Journal:  Pharmacol Ther       Date:  2019-04-08       Impact factor: 12.310

3.  Nmnat restores neuronal integrity by neutralizing mutant Huntingtin aggregate-induced progressive toxicity.

Authors:  Yi Zhu; Chong Li; Xianzun Tao; Jennifer M Brazill; Joun Park; Zoraida Diaz-Perez; R Grace Zhai
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-04       Impact factor: 11.205

4.  The E3 ligase Highwire promotes synaptic transmission by targeting the NAD-synthesizing enzyme dNmnat.

Authors:  Alexandra Russo; Pragya Goel; E J Brace; Chris Buser; Dion Dickman; Aaron DiAntonio
Journal:  EMBO Rep       Date:  2019-01-28       Impact factor: 8.807

Review 5.  NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential.

Authors:  Na Xie; Lu Zhang; Wei Gao; Canhua Huang; Peter Ernst Huber; Xiaobo Zhou; Changlong Li; Guobo Shen; Bingwen Zou
Journal:  Signal Transduct Target Ther       Date:  2020-10-07

Review 6.  Role of Nicotinamide Adenine Dinucleotide and Related Precursors as Therapeutic Targets for Age-Related Degenerative Diseases: Rationale, Biochemistry, Pharmacokinetics, and Outcomes.

Authors:  Nady Braidy; Jade Berg; James Clement; Fatemeh Khorshidi; Anne Poljak; Tharusha Jayasena; Ross Grant; Perminder Sachdev
Journal:  Antioxid Redox Signal       Date:  2018-05-11       Impact factor: 8.401

7.  PAM forms an atypical SCF ubiquitin ligase complex that ubiquitinates and degrades NMNAT2.

Authors:  Muriel Desbois; Oliver Crawley; Paul R Evans; Scott T Baker; Ikuo Masuho; Ryohei Yasuda; Brock Grill
Journal:  J Biol Chem       Date:  2018-07-11       Impact factor: 5.157

Review 8.  Targeting Diet and Exercise for Neuroprotection and Neurorecovery in Glaucoma.

Authors:  James R Tribble; Flora Hui; Melissa Jöe; Katharina Bell; Vicki Chrysostomou; Jonathan G Crowston; Pete A Williams
Journal:  Cells       Date:  2021-02-01       Impact factor: 6.600

Review 9.  NAD+ Metabolism, Metabolic Stress, and Infection.

Authors:  Benjamin Groth; Padmaja Venkatakrishnan; Su-Ju Lin
Journal:  Front Mol Biosci       Date:  2021-05-19

Review 10.  Axonal mRNA translation in neurological disorders.

Authors:  Julie Qiaojin Lin; Francesca W van Tartwijk; Christine E Holt
Journal:  RNA Biol       Date:  2020-09-29       Impact factor: 4.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.